Last reviewed · How we verify
Fixed-Dose Combinations Pragmatic Randomized Implementation Trial for Blood Pressure Control
The proposed study is an effectiveness-implementation hybrid type II trial designed to evaluate the impact of provider- and patient-directed interventions on FDC use. The trial will test the effectiveness of theory-driven nudges tailored to address provider and patient barriers. All interventions will be pharmacist-driven, with pharmacists delivering information via nudges to providers and via nudges or more intensive interventions (i.e., CPA) to patients. Data to evaluate outcomes will be extracted from electronic health records.
Details
| Lead sponsor | Brigham and Women's Hospital |
|---|---|
| Phase | NA |
| Status | NOT_YET_RECRUITING |
| Enrolment | 720 |
| Start date | Fri May 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Hypertension
- Primary Care
Interventions
- Provider nudge
- Patient nudge
- Pharmacist Virtual Visit